Merck & Co
Pharmaceutical & Health Products · Lobbying Client
B
Influence Score
66/100
High Influence
$27.3M
Total Lobby Spend
7
Policy Issues
10
Lobbyists
3
Revolving Door
Merck & Co reported $27.3 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 7 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Centers for Medicare & Medicaid Services
Small Business Administration
US Senate
US House of Representatives
Dept of Transportation
National Science Foundation
Dept of Energy
Dept of Commerce
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | Covington & Burling LLP | GOV | 4 | $1.2M |
| 2020 Apr-Jun | Cassidy & Associates LLP | TAXPHACPT | 4 | $1.7M |
| 2020 Jul-Sep | Akin Gump LLP | HCRPHAMED | 3 | $1.3M |
| 2020 Oct-Dec | Cassidy & Associates LLP | TAXTRDHCR+2 | 3 | $1.4M |
| 2021 Jan-Mar | Cassidy & Associates LLP | CPTPHAHCR+1 | 3 | $1.6M |
| 2021 Apr-Jun | Cassidy & Associates LLP | MEDHCR | 3 | $1.2M |
| 2021 Jul-Sep | K&L Gates LLP | HCR | 1 | $1.3M |
| 2021 Oct-Dec | K&L Gates LLP | PHAMEDHCR+2 | 2 | $1.4M |